{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:29:23Z","timestamp":1786364963314,"version":"build-2736575974"},"reference-count":113,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Host range describes the hosts that a bacteriophage can and cannot infect. Throughout the history of phage use in various applications, phages with varying host ranges have been needed and techniques to alter a phage\u2019s host range have been developed. These include techniques that rely on spontaneous mutations and others that use genetic engineering to make designed changes. Phages with altered host ranges have been used in personalized phage therapy cases and in cocktails in clinical trials. In this review, we provide descriptions of methods for altering a phage\u2019s host range with a focus on applications to phage therapy.<\/jats:p>","DOI":"10.3390\/v18080871","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:38:09Z","timestamp":1786361889000},"page":"871","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Putting Evolution to Work: Host Range Alteration for Phage Therapy"],"prefix":"10.3390","volume":"18","author":[{"given":"Rachel","family":"Stanchek","sequence":"first","affiliation":[{"name":"Department of Biology & Toxicology, Ashland University, Ashland, OH 44805, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-4993","authenticated-orcid":false,"given":"Paul","family":"Hyman","sequence":"additional","affiliation":[{"name":"Department of Biology & Toxicology, Ashland University, Ashland, OH 44805, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hyman, P., and Abedon, S.T. (2010). Bacteriophage Host Range and Bacterial Resistance. Advances in Applied Microbiology, Academic Press Inc.","DOI":"10.1016\/S0065-2164(10)70007-1"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Jia, H.J., Jia, P.P., Yin, S., Bu, L.K., Yang, G., and Pei, D.S. (2023). Engineering bacteriophages for enhanced host range and efficacy: Insights from bacteriophage-bacteria interactions. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1172635"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Hyman, P. (2019). Phages for phage therapy: Isolation, characterization, and host range breadth. Pharmaceuticals, 12.","DOI":"10.3390\/ph12010035"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zhou, S., Sun, Z., Liu, L., Xi, Y., Zhou, L., Yang, Z., and Zhou, J. (2026). Overcoming multidrug resistance: Antimicrobial peptides as a next-generation therapeutic strategy. Front. Cell. Infect. Microbiol., 16.","DOI":"10.3389\/fcimb.2026.1745427"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Azeredo, J., and Sillankorva, S. (2024). Guidelines to Compose an Ideal Bacteriophage Cocktail. Bacteriophage Therapy: From Lab to Clinical Practice, Springer.","DOI":"10.1007\/978-1-0716-3523-0"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00954-17","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage cocktails and the future of phage therapy","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Martinez-Soto, C.E., Cuci\u0107, S., Lin, J.T., Kirst, S., Mahmoud, E.S., Khursigara, C.M., and Anany, H. (2021). PHIDA: A high throughput turbidimetric data analytic tool to compare host range profiles of bacteriophages isolated using different enrichment methods. Viruses, 13.","DOI":"10.3390\/v13112120"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mattila, S., Ruotsalainen, P., and Jalasvuori, M. (2015). On-demand isolation of bacteriophages against drug-resistant bacteria for personalized phage therapy. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.01271"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Jdeed, G., Kravchuk, B., and Tikunova, N.V. (2025). Factors Affecting Phage\u2013Bacteria Coevolution Dynamics. Viruses, 17.","DOI":"10.3390\/v17020235"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"fuad038","DOI":"10.1093\/femsre\/fuad038","article-title":"Drivers and consequences of bacteriophage host range","volume":"47","author":"Holtappels","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41559-020-01364-1","article-title":"Host diversity slows bacteriophage adaptation by selecting generalists over specialists","volume":"5","author":"Sant","year":"2021","journal-title":"Nat. Ecol. Evol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"d\u2019H\u00e9relle, F., and Smith, G. (1926). The Bacteriophage and Its Behavior, The Williams & Wilkins Co.","DOI":"10.5962\/bhl.title.7308"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(45)90039-0","article-title":"Typing of Staphylococci by the Bacteriophage Method","volume":"245","author":"Wilson","year":"1945","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4161\/bact.19274","article-title":"Phage-based platforms for the clinical detection of human bacterial pathogens","volume":"2","author":"Schofield","year":"2012","journal-title":"Bacteriophage"},{"key":"ref_16","first-page":"165","article-title":"The Laboratory Identification of the V Form of B. typhosus","volume":"27","author":"Craigie","year":"1936","journal-title":"Can. Public Health J."},{"key":"ref_17","first-page":"448","article-title":"Demonstration of Types of B. typhosus by Means of Preparations of Type II Vi Phage","volume":"29","author":"Craigie","year":"1938","journal-title":"Can. Public Health J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0022172400056187","article-title":"Bacteriophage-typing designations of Salmonella typhimurium","volume":"78","author":"Anderson","year":"1977","journal-title":"J. Hyg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"19471","DOI":"10.2807\/ese.15.04.19471-en","article-title":"Phage typing of Salmonella typhimurium\u2014Is it still a useful tool for surveillance and outbreak investigation?","volume":"15","author":"Baggesen","year":"2010","journal-title":"Eurosurveillance"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1017\/S002217240003610X","article-title":"Investigations on the typing of staphylococci by means of bacteriophage I. The origin and nature of lysogenic strains","volume":"46","author":"Smith","year":"1948","journal-title":"J. Hyg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/am.21.4.774-776.1971","article-title":"Preliminary report of a new system for typing Salmonella typhimurium in the United States","volume":"21","author":"Wilson","year":"1971","journal-title":"Appl. Microbiol."},{"key":"ref_22","first-page":"186","article-title":"Use of host modified bacteriophages in development of a phage typing scheme for Clostridium perfringens","volume":"46","author":"Yan","year":"1989","journal-title":"Med. Lab. Sci."},{"key":"ref_23","first-page":"87","article-title":"Bacteriophage Typing of Mycobacterium ranae (Fortuitum). The Use of Unadapted and Adapted Phages in the Development of a Typing System","volume":"82","author":"Grange","year":"1974","journal-title":"Acta Pathol. Microbiol. Scand. Sect. B Microbiol. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF02122714","article-title":"Studies on bacteriophages of Propionibacterium acnes","volume":"161","author":"Jong","year":"1975","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"He, P., Cao, F., Qu, Q., Geng, H., Yang, X., Xu, T., Wang, R., Jia, X., Lu, M., and Zeng, P. (2024). Host range expansion of Acinetobacter phage vB_Ab4_Hep4 driven by a spontaneous tail tubular mutation. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1301089"},{"key":"ref_26","first-page":"87","article-title":"Host Range Expansion of Pseudomonas Virus LUZ7 Is Driven by a Conserved Tail Fiber Mutation","volume":"1","author":"Boon","year":"2020","journal-title":"PHAGE Ther. Appl. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e01209-19","DOI":"10.1128\/AEM.01209-19","article-title":"Correlation of host range expansion of therapeutic bacteriophage sb-1 with allele state at a hypervariable repeat locus","volume":"85","author":"Sergueev","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"ref_29","first-page":"1098","article-title":"Le dosage du Bacteriophage","volume":"85","author":"Appelmans","year":"1921","journal-title":"Compt. Rend. Soc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Glonti, T., and Pirnay, J.P. (2022). In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success. Viruses, 14.","DOI":"10.3390\/v14071490"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Burrowes, B.H., Molineux, I.J., and Fralick, J.A. (2019). Directed in vitro evolution of therapeutic bacteriophages: The Appelmans protocol. Viruses, 11.","DOI":"10.3390\/v11030241"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e01439-23","DOI":"10.1128\/aac.01439-23","article-title":"The virtue of training: Extending phage host spectra against vancomycin-resistant Enterococcus faecium strains using the Appelmans method","volume":"68","author":"Lossouarn","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11262-024-02124-0","article-title":"Appelmans Protocol for in vitro Klebsiella pneumoniae phage host range expansion leads to induction of the novel temperate linear plasmid prophage vB_KpnS-KpLi5","volume":"61","author":"Jakob","year":"2025","journal-title":"Virus Genes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e00884-24","DOI":"10.1128\/aem.00884-24","article-title":"Directed evolution of bacteriophages: Thwarted by prolific prophage","volume":"90","author":"Peters","year":"2024","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1096995","DOI":"10.1080\/21597081.2015.1096995","article-title":"Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa","volume":"6","author":"Mapes","year":"2016","journal-title":"Bacteriophage"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e00850-24","DOI":"10.1128\/msystems.00850-24","article-title":"Potential of training of anti-Staphylococcus aureus therapeutic phages against Staphylococcus epidermidis multidrug-resistant isolates is restricted by inter- and intra-sequence type specificity","volume":"9","author":"Kolenda","year":"2024","journal-title":"mSystems"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"199272","DOI":"10.1016\/j.virusres.2023.199272","article-title":"Appelmans protocol\u2014A directed in vitro evolution enables induction and recombination of prophages with expanded host range","volume":"339","author":"Vu","year":"2024","journal-title":"Virus Res."},{"key":"ref_38","first-page":"68","article-title":"In Vitro Evolution to Increase the Titers of Difficult Bacteriophages: RAMP-UP Protocol","volume":"4","author":"Kok","year":"2023","journal-title":"PHAGE Ther. Appl. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e00211-21","DOI":"10.1128\/mBio.00211-21","article-title":"Antiviral resistance and phage counter adaptation to antibiotic-resistant extraintestinal pathogenic Escherichia coli","volume":"12","author":"Salazar","year":"2021","journal-title":"mBio"},{"key":"ref_40","unstructured":"Clark, J., Green, S., Salazar, K., Terwilliger, A., and Maresso, A. (2020). Systems and Methods for Generating Bacteriophages Adapted to Infect a Target Bacterial Strain. (12,577,538 B2), U.S. Patent."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e01576-17","DOI":"10.1128\/AEM.01576-17","article-title":"Alterations in gp37 expand the host range of a T4-like phage","volume":"83","author":"Chen","year":"2017","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Le, S., He, X., Tan, Y., Huang, G., Zhang, L., Lux, R., Shi, W., and Hu, F. (2013). Mapping the Tail Fiber as the Receptor Binding Protein Responsible for Differential Host Specificity of Pseudomonas aeruginosa Bacteriophages PaP1 and JG004. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068562"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF00271483","article-title":"Induction of mutations in specific genes of bacteriophage T4 using cloned restriction fragments and marker rescue","volume":"177","author":"Showe","year":"1980","journal-title":"MGG Mol. Gen. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nbt.3043","article-title":"Exploiting CRISPR-cas nucleases to produce sequence-specific antimicrobials","volume":"32","author":"Bikard","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/nbt.3011","article-title":"Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases","volume":"32","author":"Citorik","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0928-8244(03)00181-0","article-title":"A rapid and simple method for inactivating chromosomal genes in Yersinia","volume":"38","author":"Derbise","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Marinelli, L.J., Piuri, M., Swigo\u0148ov\u00e1, Z., Balachandran, A., Oldfield, L.M., van Kessel, J.C., and Hatfull, G.F. (2008). BRED: A simple and powerful tool for constructing mutant and recombinant bacteriophage genomes. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003957"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1038\/s41598-021-86112-6","article-title":"CRISPY-BRED and CRISPY-BRIP: Efficient bacteriophage engineering","volume":"11","author":"Wetzel","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Song, J., Liu, Z., Zhang, Q., Liu, Y., and Chen, Y. (2023). Phage Engineering for Targeted Multidrug-Resistant Escherichia coli. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032459"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Chen, Y., Li, X., Wang, S., Qian, P., and Li, Y. (2021). CRISPR-Cas9-Mediated Genome Editing in Escherichia coli Bacteriophages. CRISPR-Cas Methods, Springer.","DOI":"10.1007\/978-1-0716-1657-4_21"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.celrep.2019.09.062","article-title":"Reprogramming Bacteriophage Host Range through Structure-Guided Design of Chimeric Receptor Binding Proteins","volume":"29","author":"Dunne","year":"2019","journal-title":"Cell Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1073\/pnas.1714658115","article-title":"Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria","volume":"115","author":"Kilcher","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cels.2015.08.013","article-title":"Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing","volume":"1","author":"Ando","year":"2015","journal-title":"Cell Syst."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/acssynbio.1c00319","article-title":"Directed Evolution of Replication-Competent Double-Stranded DNA Bacteriophage toward New Host Specificity","volume":"11","author":"Liang","year":"2022","journal-title":"ACS Synth. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40259-021-00480-z","article-title":"Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future","volume":"35","year":"2021","journal-title":"BioDrugs"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.drudis.2021.06.013","article-title":"A commentary on the development of engineered phage as therapeutics","volume":"26","author":"Barnard","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/0109298665372719250616085616","article-title":"Engineered Bacteriophages: Advances in Phage Genome Redesign Strategies for Therapeutic and Environmental Applications","volume":"32","author":"Rezaei","year":"2025","journal-title":"Protein Pept. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1128\/jb.171.8.4378-4384.1989","article-title":"A component of the side tail fiber of Escherichia coli bacteriophage lambda can functionally replace the receptor-recognizing part of a long tail fiber protein of the unrelated bacteriophage T4","volume":"171","author":"Montag","year":"1989","journal-title":"J. Bacteriol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0022-2836(05)80324-9","article-title":"Receptor-recognizing proteins of T-even type bacteriophages. The receptor-recognizing area of proteins 37 of phages T4 TuIa and TuIb","volume":"216","author":"Montag","year":"1990","journal-title":"J. Mol. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/jmbi.1996.0281","article-title":"Bacteriophage T4 host range is expanded by duplications of a small domain of the tail fiber adhesin","volume":"258","author":"Repoila","year":"1996","journal-title":"J. Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1574-6968.2009.01588.x","article-title":"Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity","volume":"295","author":"Mahichi","year":"2009","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12250-020-00233-2","article-title":"Recombination of T4-like Phages and Its Activity against Pathogenic Escherichia coli in Planktonic and Biofilm Forms","volume":"35","author":"Li","year":"2020","journal-title":"Virol. Sin."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e0089522","DOI":"10.1128\/aem.00895-22","article-title":"Expansion of the Plaquing Host Range and Improvement of the Absorption Rate of a T5-like Salmonella Phage by Altering the Long Tail Fibers","volume":"88","author":"Zhang","year":"2022","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Zheng, X., Wang, X., Li, P., Zhou, Y., Zhu, X., Hu, Z., Wang, H., Chen, M., Huo, X., and Liu, Y. (2025). The change of long tail fibers expanded the host range of a T5-like Salmonella phage and its application in milk. BMC Microbiol., 25.","DOI":"10.1186\/s12866-025-03895-8"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Hyman, P., and Denyes, J. (2018). Bacteriophages in Nanotechnology: History and Future. Bacteriophages, Springer International Publishing.","DOI":"10.1007\/978-3-319-40598-8_22-1"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2019.09.015","article-title":"Engineering Phage Host-Range and Suppressing Bacterial Resistance through Phage Tail Fiber Mutagenesis","volume":"179","author":"Yehl","year":"2019","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Huss, P., Chitboonthavisuk, C., Meger, A., Nishikawa, K., Oates, R.P., Mills, H., Holzhaus, O., and Raman, S. (2026). Microgravity reshapes bacteriophage-host coevolution aboard the International Space Station. PLoS Biol., 24.","DOI":"10.1371\/journal.pbio.3003568"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Anastassopoulou, C., Tsakri, D., Panagiotopoulos, A.P., Saldari, C., Sagona, A.P., and Tsakris, A. (2025). Armed Phages: A New Weapon in the Battle Against Antimicrobial Resistance. Viruses, 17.","DOI":"10.3390\/v17070911"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Guo, D., Chen, J., Zhao, X., Luo, Y., Jin, M., Fan, F., Park, C., Yang, X., Sun, C., and Yan, J. (2021). Genetic and chemical engineering of phages for controlling multidrug-resistant bacteria. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020202"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e2407268","DOI":"10.1002\/adma.202407268","article-title":"The Guardian of Vision: Intelligent Bacteriophage-Based Eyedrops for Clinical Multidrug-Resistant Ocular Surface Infections","volume":"36","author":"Chen","year":"2024","journal-title":"Adv. Mater."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"10097","DOI":"10.2147\/IJN.S479960","article-title":"Long-Term Effectiveness of Engineered T7 Phages Armed with Silver Nanoparticles Against Escherichia coli Biofilm","volume":"19","author":"Szymczak","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2105668","DOI":"10.1002\/advs.202105668","article-title":"Photocatalytic Quantum Dot-Armed Bacteriophage for Combating Drug-Resistant Bacterial Infection","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"11197","DOI":"10.1073\/pnas.0704624104","article-title":"Dispersing biofilms with engineered enzymatic bacteriophage","volume":"104","author":"Lu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1093\/nar\/gky544","article-title":"A functional type II-A CRISPR-Cas system from Listeria enables efficient genome editing of large non-integrating bacteriophage","volume":"46","author":"Hupfeld","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"107295","DOI":"10.1016\/j.jbc.2024.107295","article-title":"Unity among the diverse RNA-guided CRISPR-Cas interference mechanisms","volume":"300","author":"Ganguly","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Lee, C.K., Lee, H.J., Jeong, S.H., and Lee, S.J. (2025). Precision targeting of genetic variations in mixed bacterial cultures using CRISPR-Cas12a-programmed \u03bb phages. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1575339"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41587-023-01759-y","article-title":"Engineered phage with antibacterial CRISPR\u2013Cas selectively reduce E. coli burden in mice","volume":"42","author":"Gencay","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"101257","DOI":"10.1016\/j.lanmic.2025.101257","article-title":"Safety, recovery, and pharmacodynamics of CRISPR\u2013Cas therapeutic SNIPR001: A phase 1, randomised, double-blind, first-in-human, dose-escalation study","volume":"7","author":"Petersen","year":"2026","journal-title":"Lancet Microbe"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1473-3099(24)00424-9","article-title":"Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): The randomised, open-label, first part of a two-part phase 2 trial","volume":"24","author":"Kim","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e10381","DOI":"10.1002\/btm2.10381","article-title":"Phage engineering and phage-assisted CRISPR-Cas delivery to combat multidrug-resistant pathogens","volume":"8","author":"Khambhati","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e02115-24","DOI":"10.1128\/aem.02115-24","article-title":"Antimicrobial peptides: From discovery to developmental applications","volume":"91","author":"Zhang","year":"2025","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1021\/acs.nanolett.5b01943","article-title":"Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies","volume":"15","author":"Krom","year":"2015","journal-title":"Nano Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12275-019-8686-6","article-title":"Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018","volume":"57","author":"Lemon","year":"2019","journal-title":"J. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.chembiol.2010.07.007","article-title":"Structural studies of a peptide with immune modulating and direct antimicrobial activity","volume":"17","author":"Wieczorek","year":"2010","journal-title":"Chem. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.3390\/cimb44060174","article-title":"Construction and Characterization of T7 Bacteriophages Harboring Apidaecin-Derived Sequences","volume":"44","author":"Ludwig","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Ludwig, T., Volke, D., and Krizsan, A. (2025). Analysis of engineered T7 bacteriophages containing genetic sequences encoding antimicrobial peptides. Front. Antibiot., 3.","DOI":"10.3389\/frabi.2024.1515874"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"107734","DOI":"10.1016\/j.ijantimicag.2026.107734","article-title":"CRISPR\/Cas9-engineered Salmonella phage displaying antimicrobial peptide LL37 for enhanced antibacterial activity","volume":"67","author":"Jo","year":"2026","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1128\/jb.172.12.6900-6906.1990","article-title":"Binding of DNA in vitro by a small, acid-soluble spore protein from Bacillus subtilis and the effect of this binding on DNA topology","volume":"172","author":"Nicholson","year":"1990","journal-title":"J. Bacteriol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1128\/jb.173.5.1642-1653.1991","article-title":"Synthesis of a Bacillus subtilis small, acid-soluble spore protein in Escherichia coli causes cell DNA to assume some characteristics of spore DNA","volume":"173","author":"Setlow","year":"1991","journal-title":"J. Bacteriol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1358\/dnp.2009.22.4.1367708","article-title":"SASP gene delivery: A novel antibacterial approach","volume":"22","author":"Fairhead","year":"2009","journal-title":"Drug News Perspect."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Cass, J., Barnard, A., and Fairhead, H. (2021). Engineered bacteriophage as a delivery vehicle for antibacterial protein, sasp. Pharmaceuticals, 14.","DOI":"10.3390\/ph14101038"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s44259-025-00096-1","article-title":"Antibiotics re-booted\u2014Time to kick back against drug resistance","volume":"3","author":"Blaskovich","year":"2025","journal-title":"npj Antimicrob. Resist."},{"key":"ref_93","unstructured":"BusinessCloud (2024). BGF-Backed Phico Enters Liquidation, BusinessCloud. Available online: https:\/\/businesscloud.co.uk\/news\/bgf-backed-phico-enters-liquidation\/."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0042-6822(87)90324-2","article-title":"Two DNA antirestriction systems of bacteriophage P1, darA, and darB: Characterization of darA-phages","volume":"157","author":"Iida","year":"1987","journal-title":"Virology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1128\/AEM.02229-13","article-title":"Bacteriophage orphan DNA methyltransferases: Insights from their bacterial origin, function, and occurrence","volume":"79","author":"Murphy","year":"2013","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1128\/jvi.19.1.136-145.1976","article-title":"SAMase gene of bacteriophage T3 is responsible for overcoming host restriction","volume":"19","author":"Studier","year":"1976","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/s41564-024-01851-2","article-title":"A widespread phage-encoded kinase enables evasion of multiple host antiphage defence systems","volume":"9","author":"Jiang","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"168041","DOI":"10.1016\/j.jmb.2023.168041","article-title":"Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type II Anti-CRISPR Proteins","volume":"435","author":"Hwang","year":"2023","journal-title":"J. Mol. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1038\/s41564-025-02178-2","article-title":"A phage-encoded anti-CRISPR protein co-opts host enolase to prevent type III CRISPR immunity","volume":"10","author":"Johnson","year":"2025","journal-title":"Nat. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s42003-025-07730-8","article-title":"Phage engineering to overcome bacterial Tmn immunity in Dhillonvirus","volume":"8","author":"Yamashita","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2958.2012.07975.x","article-title":"Dmd of bacteriophage T4 functions as an antitoxin against Escherichia coli LsoA and RnlA toxins","volume":"83","author":"Otsuka","year":"2012","journal-title":"Mol. Microbiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41586-022-04716-y","article-title":"Phage anti-CBASS and anti-Pycsar nucleases subvert bacterial immunity","volume":"605","author":"Hobbs","year":"2022","journal-title":"Nature"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.molcel.2020.12.011","article-title":"A phage-encoded anti-activator inhibits quorum sensing in Pseudomonas aeruginosa","volume":"81","author":"Shah","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"dlae017","DOI":"10.1093\/jacamr\/dlae017","article-title":"Improving phage therapy by evasion of phage resistance mechanisms","volume":"6","author":"Bleriot","year":"2024","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41586-023-06869-w","article-title":"Phages overcome bacterial immunity via diverse anti-defence proteins","volume":"625","author":"Yirmiya","year":"2024","journal-title":"Nature"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/jb.123.1.102-117.1975","article-title":"Genetics of resistance to colicins in Escherichia coli K-12: Cross-resistance among colicins of group A","volume":"123","author":"Davies","year":"1975","journal-title":"J. Bacteriol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1006\/jmbi.2001.4578","article-title":"The TolC protein of Escherichia coli serves as a cell-surface receptor for the newly characterized TLS bacteriophage 1 1Edited by B. Holland","volume":"308","author":"German","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1073\/pnas.1919888117","article-title":"Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance","volume":"117","author":"Burmeister","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"26717","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa","volume":"6","author":"Chan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/emph\/eoy005","article-title":"Phage treatment of an aortic graft infected with Pseudomonas aeruginosa","volume":"2018","author":"Chan","year":"2018","journal-title":"Evol. Med. Public Health"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Valappil, S.K., Shetty, P., Deim, Z., Terhes, G., Urb\u00e1n, E., V\u00e1czi, S., Patai, R., Polg\u00e1r, T., Pertics, B.Z., and Schneider, G. (2021). Survival Comes at a Cost: A Coevolution of Phage and Its Host Leads to Phage Resistance and Antibiotic Sensitivity of Pseudomonas aeruginosa Multidrug Resistant Strains. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.783722"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e02914-22","DOI":"10.1128\/spectrum.02914-22","article-title":"Fitness Trade-Offs in Phage Cocktail-Resistant Salmonella enterica Serovar Enteritidis Results in Increased Antibiotic Susceptibility and Reduced Virulence","volume":"10","author":"Gao","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Villarroel, J., Larsen, M.V., Kilstrup, M., and Nielsen, M. (2017). Metagenomic Analysis of Therapeutic PYO Phage Cocktails from 1997 to 2014. Viruses, 9.","DOI":"10.3390\/v9110328"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/871\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:41:44Z","timestamp":1786362104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":113,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["v18080871"],"URL":"https:\/\/doi.org\/10.3390\/v18080871","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}